Wissenschaftliche Arbeiten

Prof. Dr. Erkan Çakır

308 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Determination of the yearly distribution of the incidence of Allergic Bronchopulmonary Aspergillosis (ABPA) in patients registered in the cystic fibrosis patient registry system of Turkey and identification of risk factors for its development

    Chronic Illness, 2026

    DOI 10.1177/17423953261452631 PMID 42216671 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Pulmonary Hypertension in Childhood Interstitial Lung Disease: Prevalence, Clinical Course, and Prognostic Impact from a National Registry

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3985 Quelle: OpenAlex

  3. Current status of childhood interstitial lung disease in Turkiye: 5-year data from ChILD-TR

    BMJ Open Respiratory Research, 2026

    DOI 10.1136/bmjresp-2026-004626 PMID 42971729 Frei zugänglicher VolltextQuelle: OpenAlex

  4. Clinical characteristics and risk factors of patients with cystic fibrosis-related diabetes and pre-diabetes: cohort of cystic fibrosis registry of Türkiye

    Journal of Pediatric Endocrinology and Metabolism, 2026

    DOI 10.1515/jpem-2025-0749 PMID 42048225 Quelle: OpenAlex

  5. National Registry Analysis Of Pseudomonas Aeruginosa Monoinfection And Coinfection With Methicillin-Susceptible Staphylococcus Aureus In Cystic Fibrosis

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa801 Quelle: OpenAlex

  6. Multidrug-Resistant and Difficult-to-Treat Pseudomonas aeruginosa in Cystic Fibrosis: A Nationwide Registry Analysis from Türkiye

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3943 Quelle: OpenAlex

  7. An analysis of cystic fibrosis transmembrane conductance regulator gene variants in the Cystic Fibrosis Registry of Türkiye

    European Journal of Pediatrics, 2026

    DOI 10.1007/s00431-026-07498-x PMID 42963477 Quelle: OpenAlex

  8. Evaluation of the Clinical and Genetic Characteristics of Primary Ciliary Dyskinesia Patients With Situs Inversus Totalis

    Birth Defects Research, 2025

    DOI 10.1002/bdr2.2444 PMID 39902670 2 Zitationen (Europe PMC) Quelle: OpenAlex

  9. Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of Türkiye

    The Turkish Journal of Pediatrics, 2025

    DOI 10.24953/turkjpediatr.2025.4680 PMID 40084730 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Effective Pseudomonas aeruginosa Eradication in Cystic Fibrosis: Multicenter Study

    Clinical Pediatrics, 2025

    DOI 10.1177/00099228251351699 PMID 40576045 1 Zitation (Europe PMC) Quelle: OpenAlex

  11. National Registry for Home Mechanical Ventilation in Children from Turkey

    Respiration, 2025

    DOI 10.1159/000543343 PMID 39809249 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  12. A retrospective cohort study of children diagnosed with Cystic Fibrosis after implementation of a newborn screening program in Turkey

    Respiratory Medicine, 2025

    DOI 10.1016/j.rmed.2025.108047 PMID 40122405 1 Zitation (Europe PMC) Quelle: OpenAlex

  13. Impact of Modulator Therapy on the Chronic Colonization of Lower Respiratory Tract Pathogens in Children: Data From Cystic Fibrosis Registry of Turkey

    Pediatric Pulmonology, 2025

    DOI 10.1002/ppul.71155 PMID 40504038 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  14. P226 Impact of modulator therapy on the chronic colonization of lower respiratory tract pathogens in children: data from the cystic fibrosis registry of Turkey

    Journal of Cystic Fibrosis, 2025

    DOI 10.1016/j.jcf.2025.03.1112 Quelle: OpenAlex

  15. P169 Allergic bronchopulmonary aspergillosis in Turkey - the incidence and identification of risk factors for its development

    Journal of Cystic Fibrosis, 2025

    DOI 10.1016/j.jcf.2025.03.1055 Quelle: OpenAlex

  16. Eradication of Methicillin-Resistant Staphylococcus aureus in Cystic Fibrosis

    Clinical Pediatrics, 2025

    DOI 10.1177/00099228251375413 PMID 41035301 Quelle: OpenAlex

  17. The Importance of Bronchoalveolar Lavage Findings in Diagnosis and Their Relationship with Radiological Findings in Pediatric Interstitial Lung Diseases: Turkey chILD National Registry Cohort Study

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa558 Quelle: OpenAlex

  18. Long‐Term Outcomes of Necrotizing Pneumonia and Parapneumonic Effusion in Children

    Pediatric Pulmonology, 2025

    DOI 10.1002/ppul.71241 PMID 40827719 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  19. The long-term efficacy of nusinersen on respiratory functions in children with symptomatic spinal muscular atrophy type 1

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2025

    DOI 10.55730/1300-0144.6018 PMID 40686700 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Comparison of interrupted and continuous modulator therapy in cystic fibrosis: a real life experience in Turkey

    Frontiers in Pediatrics, 2025

    DOI 10.3389/fped.2025.1659633 PMID 41158800 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  21. Current Status of Cystic Fibrosis in Türkiye: Data from the National Registry

    Thoracic research and practice, 2025

    DOI 10.4274/thoracrespract.2025.2025-1-11 PMID 40785313 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  22. P384 Evaluation of rare cystic fibrosis transmembrane conductance regulator gene variants according to seven functional classes from Turkish National Cystic Fibrosis Patient Registry

    Journal of Cystic Fibrosis, 2025

    DOI 10.1016/j.jcf.2025.03.1268 Quelle: OpenAlex

  23. Sit-to-Stand Test: A Practical Tool for Evaluating Exercise Capacity in Children with Chronic Respiratory Disease

    Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi, 2025

    DOI 10.46413/boneyusbad.1615116 Quelle: OpenAlex

  24. Increasing Cystic Fibrosis Knowledge of Parents of Children Diagnosed With the Newborn Screening Program

    Pediatric Pulmonology, 2025

    DOI 10.1002/ppul.71392 PMID 41255258 Frei zugänglicher VolltextQuelle: OpenAlex

  25. Effectiveness of the hippotherapy simulator in children and adolescents with cystic fibrosis

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa1619 Quelle: OpenAlex

  26. Comparison of newborn screening and modulatory treatment responses in siblings with cystic fibrosis

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa1625 Quelle: OpenAlex

  27. Current practices and variations in pediatric flexible bronchoscopy: First national survey of pediatric pulmonologists in Türkiye

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa3108 Quelle: OpenAlex

  28. Effectiveness of the hippotherapy simulator in children and adolescents with cystic fibrosis: A randomized controlled trial

    Heart & Lung, 2025

    DOI 10.1016/j.hrtlng.2025.102688 PMID 41385838 Quelle: OpenAlex

  29. Evaluation of the association of mucosa-associated invariant T (MAIT) cells with childhood asthma

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024

    DOI 10.55730/1300-0144.5908 PMID 39734354 Frei zugänglicher VolltextQuelle: OpenAlex

  30. Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators

    Pediatric Pulmonology, 2024

    DOI 10.1002/ppul.27051 PMID 38771207 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  31. Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study

    Pediatric Pulmonology, 2024

    DOI 10.1002/ppul.27165 PMID 38980199 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  32. Short-term azithromycin use is associated with QTc interval prolongation in children with cystic fibrosis

    Archives de Pédiatrie, 2024

    DOI 10.1016/j.arcped.2024.02.004 PMID 38637249 Quelle: OpenAlex

  33. P005 Seven-year follow-up of patients with cystic fibrosis after newborn screening program

    Journal of Cystic Fibrosis, 2024

    DOI 10.1016/s1569-1993(24)00313-8 Quelle: OpenAlex

  34. P001 Evaluation of the relationship between quantitative levels of immunereactive trypsinogen & sweat chloride levels, genetic mutations, and pancreatic involvement in cystic fibrosis patients

    Journal of Cystic Fibrosis, 2024

    DOI 10.1016/s1569-1993(24)00309-6 Frei zugänglicher VolltextQuelle: OpenAlex

  35. P031 Determining the genotypic and phenotypic characteristics of patients in the Turkish National Cystic Fibrosis Registry System

    Journal of Cystic Fibrosis, 2024

    DOI 10.1016/s1569-1993(24)00339-4 Quelle: OpenAlex

  36. Comparison of refugee patients with cystic fibrosis and their counterpart children from Turkey during the war

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05431-8 PMID 38265526 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  37. Implementation of a high fidelity simulation based training program for physicians of children requiring long term invasive home ventilation: a study by ISPAT team

    Frontiers in Pediatrics, 2024

    DOI 10.3389/fped.2024.1325582 PMID 38362002 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  38. The Association between Aminoglycoside Exposure and Ototoxicity in Children with Cystic Fibrosis

    Respiration, 2024

    DOI 10.1159/000541447 PMID 39299224 1 Zitation (Europe PMC) Quelle: OpenAlex

  39. Evaluation of postinfectious bronchiolitis obliterans patients in the Childhood Interstitial Lung Diseases Registry of Türkiye

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa4956 Quelle: OpenAlex

  40. The relationship of sit-to-stand tests with 6-minute walk test in children with chronic respiratory diseases

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.pa3202 Quelle: OpenAlex

  41. NATIONAL REGISTRY SYSTEM FOR HOME MECHANICAL VENTILATION SUPPORT IN CHILDREN: FIRST DATA FROM TURKEY

    European Respiratory Journal, 2024

    DOI 10.1183/13993003.congress-2024.oa4656 Quelle: OpenAlex

  42. Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?

    Pediatric Pulmonology, 2023

    DOI 10.1002/ppul.26535 PMID 37278544 10 Zitationen (Europe PMC) Quelle: OpenAlex

  43. Clinical and Radiological Evaluation and Follow-Up of Patients with Noncardiac Plastic Bronchitis

    Turkish Archives of Pediatrics, 2023

    DOI 10.5152/turkarchpediatr.2023.23052 PMID 37670550 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  44. Long‐term outcomes of standardized training for caregivers of children with tracheostomies: The IStanbul PAediatric Tracheostomy (ISPAT) project

    Pediatric Pulmonology, 2023

    DOI 10.1002/ppul.26749 PMID 37983721 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  45. Clinical characteristics of patients requiring lung transplantation referral in national cystic fibrosis registry data

    The Turkish Journal of Pediatrics, 2023

    DOI 10.24953/turkjped.2021.4930 PMID 37114691 2 Zitationen (Europe PMC) Quelle: OpenAlex

  46. Foreign Body Aspiration in Children

    Springer eBooks, 2023

    DOI 10.1007/978-3-031-22483-6_106-1 Quelle: OpenAlex

  47. P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey

    Journal of Cystic Fibrosis, 2023

    DOI 10.1016/s1569-1993(23)00597-0 Quelle: OpenAlex

  48. The Relationship Between ABO-Rh Blood Types and Disease Severity in Children with COVID-19 Infection

    Pediatric Practice and Research, 2023

    DOI 10.21765/pprjournal.1320697 Frei zugänglicher VolltextQuelle: OpenAlex

  49. Evaluation of respiratory function at 6 years of age in patients with cystic fibrosis with frequent pulmonary exacerbations in the first 2 years of life

    European Respiratory Journal, 2023

    DOI 10.1183/13993003.congress-2023.pa5012 Quelle: OpenAlex

  50. Childhood interstitial lung disease in Turkey: first data from the national registry

    European Journal of Pediatrics, 2023

    DOI 10.1007/s00431-023-05290-9 PMID 37875631 20 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex